In fact, reduced concentrations of IgA, IgG and IgM were seen in all MS patients who underwent apheresis (n=6), with the decrease in IgG levels being highly significant (from 4.21 to 0.82 g/L or -81% on average, p=0.002). This evidence concerns the gene CD79A and myeloid sarcoma.